Ultragenyx Pharmaceutical (RARE) Enterprise Value (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.67% |
| Dec 31, 2025 | -60.91% |
| Sep 30, 2025 | 12.97% |
| Jun 30, 2025 | 1.40% |
| Mar 31, 2025 | 19.17% |
| Dec 31, 2024 | 1.89% |
| Sep 30, 2024 | 19.54% |
| Jun 30, 2024 | -85.36% |
| Mar 31, 2024 | 28.66% |
| Dec 31, 2023 | -30.66% |
| Sep 30, 2023 | 19.91% |
| Jun 30, 2023 | 12.29% |
| Mar 31, 2023 | 15.83% |
| Dec 31, 2022 | 15.86% |
| Sep 30, 2022 | -63.72% |
| Jun 30, 2022 | 9.28% |
| Mar 31, 2022 | 19.17% |
| Dec 31, 2021 | -0.42% |
| Sep 30, 2021 | 12.85% |
| Jun 30, 2021 | 12.39% |
| Mar 31, 2021 | 19.65% |
| Dec 31, 2020 | -56.96% |
| Sep 30, 2020 | -128.08% |
| Jun 30, 2020 | 49.40% |
| Mar 31, 2020 | 12.18% |
| Dec 31, 2019 | -43.29% |
| Sep 30, 2019 | 14.75% |
| Jun 30, 2019 | 13.56% |
| Mar 31, 2019 | -55.60% |
| Dec 31, 2018 | 8.62% |
| Sep 30, 2018 | 8.05% |
| Jun 30, 2018 | -1.07% |
| Mar 31, 2018 | -130.86% |
| Dec 31, 2017 | 36.81% |
| Sep 30, 2017 | 7.15% |
| Jun 30, 2017 | 6.01% |
| Mar 31, 2017 | -11.85% |
| Dec 31, 2016 | 4.11% |
| Sep 30, 2016 | -1.18% |
| Jun 30, 2016 | 4.87% |
| Mar 31, 2016 | 5.75% |
| Dec 31, 2015 | 2.54% |
| Sep 30, 2015 | -37.53% |
| Jun 30, 2015 | 4.83% |
| Mar 31, 2015 | -82.71% |
| Dec 31, 2014 | 6.81% |
| Sep 30, 2014 | -31.27% |
| Jun 30, 2014 | 7.33% |
| Mar 31, 2014 | -6,861.15% |
| Dec 31, 2013 | 60.72% |
| Sep 30, 2013 | 55.22% |
| Jun 30, 2013 | 79.16% |